According to the National Institute for Occupational Safety and Health (NIOSH), glutaraldehyde is a pungent chemical that is commonly used as a tanning agent, a biocide in metalworking and a preservative in cosmetics. It is also used as a hardening agent in x-rays, and is a staple in embalming solutions. Furthermore, the hazardous chemical is used as an antimicrobial in water treatment systems, and remains a widely utilized tissue fixative in histology and pathology laboratories.
In the medical field, glutaraldehyde is primarily used as a cold sterilant. Healthcare practitioners use this chemical to disinfect equipment that cannot accommodate heat sterilization, such as surgical and dialysis instruments, endoscopes, bronchoscopes and various other apparatus.
Both the Occupational Safety and Health Administration (OSHA) and the Toxicology Data Network (TDN) recognize glutaraldehyde as a toxic chemical, with the latter revealing that the compound is a registered pesticide in the U.S. The chemical is so toxic that OSHA even recommends using other disinfecting methods when available.
Data from the OSHA shows that the short term effects of glutaraldehyde exposure include eye irritation and skin corrosion at high concentrations. Short term exposure to glutaraldehyde fumes may also result in nose, throat and respiratory tract irritation, headaches and nausea, nosebleeds and drowsiness. On the other hand, long term exposure to glutaraldehyde may lead to hypersensitivity. According to OSHA, long term exposure to the chemical may trigger sudden asthma attacks even at very small amounts. The health and safety watchdog has identified glutaraldehyde as as potential cause for occupational asthma. Prolonged glutaraldehyde exposure may also lead to serious skin allergies and chronic eczema.
Skin irritations, including staining, hives and allergic dermatitis, were also among health concerns tied to glutaraldehyde exposure, according to data from the NIOSH.
Studies, case reports link glutaraldehyde to various health risks
A series of studies and peer reviews in the Toxicology Data Network have associated glutaraldehyde exposure to an array of adverse health conditions. A study published in Occupational Medicine revealed that patients with glutaraldehyde-induced asthma showed a significantly higher proportion of eosinophils, basophils and lymphocytes compared with atopic asthmatics and their healthier peers. Another study revealed that healthcare personnel who had constant exposure to glutaraldehyde were eight times as likely to be allergic to the chemical than those who had not been exposed to it. (Related: CDC document bombshell reveals list of all vaccine excipients, including “African Green Monkey Kidney Cells” and fibroblast cells from aborted human fetuses … see the complete list.)
A high number of case reports compiled by the TDN has associated glutaraldehyde exposure to various adverse conditions, including chemical colitis, acute rectocolitis and dermatitis. Eczema, keratopathy and swelling were also noted in several case studies in the database.
The apparent threat at hand
Eight vaccine excipients included in the CDC list contain this hazardous chemical, most of which were used against diphteria, tetanus and pertussis. The most alarming common variable that these excipients have, patient-wise, is that they are intentionally injected into children younger than 7. DTaP vaccines themselves are laden with side effects ranging from swelling and fever, to more serious conditions such as severe allergic reactions, faster heart rate and constrained breathing. Considering the notoriety of glutaraldehyde in a number of research and case studies, its presence in these vaccine excipients raises further concerns about the already-disputed safety of vaccinations, especially among infants and children.
Visit Toxins.news and Vaccines.news to get a more in-depth analysis and discussion about the toxicology of glutaraldehyde and other vaccine excipients.
Sources include:
Please contact us for more information.
